The US biomedical research enterprise has some severe structural problems. We take a look at what’s wrong and examine one proposed remedy.
Originally Syndicated via RSS from Ars Technica


The US biomedical research enterprise has some severe structural problems. We take a look at what’s wrong and examine one proposed remedy.
Originally Syndicated via RSS from Ars Technica